These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 26688896)

  • 1. COMPARE BEFORE DECIDING. First-line cytotoxic drugs for chronic lymphocytic leukaemia.
    Prescrire Int; 2015 Nov; 24(165):263. PubMed ID: 26688896
    [No Abstract]   [Full Text] [Related]  

  • 2. Rituximab therapy in cutaneous infiltration of chronic lymphocytic leukaemia.
    Ramakrishna R; Sarathy K; Sarathy T
    Acta Haematol; 2013; 130(1):47-51. PubMed ID: 23406682
    [No Abstract]   [Full Text] [Related]  

  • 3. How I manage chronic lymphocytic leukemia in 2014.
    Alwbari A; Makhoul I
    J Ark Med Soc; 2014 Sep; 111(4):68-9. PubMed ID: 25255690
    [No Abstract]   [Full Text] [Related]  

  • 4. Dasatinib-induced response in a rare case of chronic lymphocytic leukaemia associated with chronic myeloid leukaemia.
    Tecchio C; Nichele I; Todeschini G; Pizzolo G; Ambrosetti A
    Br J Haematol; 2009 Jul; 146(2):222-3. PubMed ID: 19466973
    [No Abstract]   [Full Text] [Related]  

  • 5. Campath-1H induced pure red cell aplasia in a patient with chronic lymphatic leukaemia.
    Thachil J; Salim R
    Leuk Res; 2007 Jul; 31(7):1025-6. PubMed ID: 17005249
    [No Abstract]   [Full Text] [Related]  

  • 6. Chronic lymphocytic leukemia with eyelid involvement responding to alemtuzumab.
    Laurenti L; Tarnani M; Innocenti I; Savino G; Battendieri R; Larocca LM; Chiusolo P; Sorà F; Sica S; Efremov D; Leone G
    J Clin Oncol; 2008 Nov; 26(32):5299-301. PubMed ID: 18854557
    [No Abstract]   [Full Text] [Related]  

  • 7. Morphology, atypical chronic lymphocytic leukaemia and prognostic features affecting choice of therapy.
    Catovsky D
    Haematologica; 1999 Jun; 84 Suppl EHA-4():92-3. PubMed ID: 10907480
    [No Abstract]   [Full Text] [Related]  

  • 8. Chronic lymphocytic leukaemia responsive to vitamin D administration.
    Arlet JB; Callens C; Hermine O; Darnige L; Macintyre E; Pouchot J; Capron L
    Br J Haematol; 2012 Jan; 156(1):148-9. PubMed ID: 21883139
    [No Abstract]   [Full Text] [Related]  

  • 9. Efficacy of alemtuzumab in cutaneous chronic lymphocytic leukaemia involving facial skin.
    Grey M
    Br J Haematol; 2008 Jul; 142(1):1. PubMed ID: 18477054
    [No Abstract]   [Full Text] [Related]  

  • 10. Chronic lymphocytic leukaemia: current first-line therapy.
    Carney DA; Mulligan SP
    Intern Med J; 2009 Jan; 39(1):44-8. PubMed ID: 19290981
    [TBL] [Abstract][Full Text] [Related]  

  • 11. B-cell receptor inhibitors in chronic lymphocytic leukemia.
    Brown JR
    Clin Adv Hematol Oncol; 2013 Jun; 11(6):362-4. PubMed ID: 24472805
    [No Abstract]   [Full Text] [Related]  

  • 12. Autoimmune neutropenia following therapy for chronic lymphocytic leukaemia: a report of three cases.
    Roberts L; Lucas G; Green L; Lindsay J; Bhattacharyya S; Thornton P; Evans G; Pocock C
    Br J Haematol; 2007 Jan; 136(2):348-9. PubMed ID: 17156393
    [No Abstract]   [Full Text] [Related]  

  • 13. A phase II trial of fludarabine in patients with previously treated chronic lymphocytic leukaemia.
    Hocepied AM; Falkson CI; Falkson G
    S Afr Med J; 1996 May; 86(5):549-50. PubMed ID: 8711555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel pathway inhibitors for the treatment of chronic lymphocytic leukaemia.
    Molica S; Montserrat E
    Lancet Haematol; 2019 Feb; 6(2):e65-e66. PubMed ID: 30709435
    [No Abstract]   [Full Text] [Related]  

  • 15. When and how to treat chronic lymphocytic leukemia.
    Dighiero G; Binet JL
    N Engl J Med; 2000 Dec; 343(24):1799-801. PubMed ID: 11114321
    [No Abstract]   [Full Text] [Related]  

  • 16. Richter syndrome presenting as a solitary cerebellar tumor during first-line treatment for chronic lymphocytic leukemia.
    Fløisand Y; Delabie J; Fosså A; Helseth E; Jacobsen EA; Rolke J; Tjønnfjord GE
    Leuk Lymphoma; 2011 Oct; 52(10):2007-9. PubMed ID: 21663503
    [No Abstract]   [Full Text] [Related]  

  • 17. Alemtuzumab as first-line therapy for B-cell chronic lymphocytic leukemia: long-term follow-up of clinical effects, infectious complications and risk of Richter transformation.
    Karlsson C; Norin S; Kimby E; Sander B; Porwit Macdonald A; Nilsson B; Johansson E; Mellstedt H; Lundin J; Osterborg A
    Leukemia; 2006 Dec; 20(12):2204-7. PubMed ID: 17051245
    [No Abstract]   [Full Text] [Related]  

  • 18. Aspergillus fumigatus osteomyelitis in a patient receiving alemtuzumab for B-cell chronic lymphocytic leukaemia.
    Karia S; Jeyapalan K; Kennedy B
    Br J Haematol; 2011 Apr; 153(2):147. PubMed ID: 21332707
    [No Abstract]   [Full Text] [Related]  

  • 19. Fludarabine phosphate for the first-line treatment of chronic lymphocytic leukaemia.
    Walker S; Palmer S; Erhorn S; Brent S; Dyker A; Ferrie L; Horsley W; Macfarlane K; White S; Thomas S
    Health Technol Assess; 2009 Jun; 13 Suppl 1():35-40. PubMed ID: 19567212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Visceral leishmaniasis after alemtuzumab in a patient with chronic lymphocytic leukaemia.
    Pitini V; Cascio A; Arrigo C; Altavilla G
    Br J Haematol; 2012 Jan; 156(1):1. PubMed ID: 21790529
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.